Clinical Trial Update: A Phase II Study of CRT Combined With QL1706 in ESCC Patients [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating the combination of CRT with QL1706 in patients with Esophageal Squamous Cell Carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Chemo-radiotherapy (CRT)
• QL1706

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING